PI3K/Akt/mTOR activation by suppression of ELK3 mediates chemosensitivity of MDA-MB-231 cells to doxorubicin by inhibiting autophagy
Authors:
- 1 August 2016
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 477 (2) , 277-282
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (20120006679, 2012M3A9C6050367)
- Rural Development Administration, Republic of Korea (PJ010033)
This publication has 37 references indexed in Scilit:
- ELK3 Expression Correlates With Cell Migration, Invasion, and Membrane Type 1-Matrix Metalloproteinase Expression in MDA-MB-231 Breast Cancer CellsGene Expression, 2015
- ETS family transcriptional regulators drive chromatin dynamics and malignancy in squamous cell carcinomaseLife, 2015
- Therapeutic targeting of autophagy in cancer. Part II: Pharmacological modulation of treatment-induced autophagySeminars in Cancer Biology, 2015
- ELK3 Suppresses Angiogenesis by Inhibiting the Transcriptional Activity of ETS-1 on MT1-MMPInternational Journal of Biological Sciences, 2014
- Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatmentCell Death & Disease, 2013
- Autophagy and MetabolismScience, 2010
- Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell linesCarcinogenesis, 2009
- The ternary complex factor Net contains two distinct elements that mediate different responses to MAP kinase signalling cascadesOncogene, 2000
- The Net Repressor Is Regulated by Nuclear Export in Response to Anisomycin, UV, and Heat ShockMolecular and Cellular Biology, 1999
- Net, a new ets transcription factor that is activated by Ras.Genes & Development, 1994